ダウンロード数: 232
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
29_0009.pdf | 445.6 kB | Adobe PDF | 見る/開く |
タイトル: | いわゆる細胞性免疫能賦活剤を投与した膀胱腫瘍症例の検討 |
その他のタイトル: | Treatment of tumors of the urinary bladder with so-called immunopotentiators |
著者: | 辻村, 俊策 加藤, 次朗 上田, 公介 大田黒, 和生 |
著者名の別形: | Tsujimura, Shunsaku Kato, Jiro Ueda, Kosuke Ohtaguro, Kazuo |
キーワード: | Adjuvants, Immunologic/administration & dosage/therapeutic use Aged Antibiotics, Antineoplastic/therapeutic use Biological Products/therapeutic use Carcinoma, Squamous Cell/drug therapy/immunology Carcinoma, Transitional Cell/drug therapy/immunology Female Humans Levamisole/administration & dosage/therapeutic use Male Middle Aged Phytohemagglutinins/immunology Picibanil/administration & dosage/therapeutic use Prognosis Proteoglycans/administration & dosage/therapeutic use Skin Tests Urinary Bladder Neoplasms/drug therapy/immunology |
発行日: | Jan-1983 |
出版者: | 泌尿器科紀要刊行会 |
誌名: | 泌尿器科紀要 |
巻: | 29 |
号: | 1 |
開始ページ: | 9 |
終了ページ: | 15 |
抄録: | Eighty-eight cases of urinary bladder tumor were treated in our Department from 1976 to 1978. The effect of so-called immunopotentiators (OK-432, Levamisole and PSK) was studied in 23 patients. The following results were obtained. Pretreatment intracutaneous response to PHA was significantly lower in the high stage and high grade group than in the low stage and low grade group (P less than 0.025). However, there was no correlation between the effect of immunotherapy and PHA skin reaction. Of the immunoglobulins, only IgM was significantly lower in the high grade group than in the low grade group (P less than 0.025). The one-year survival rate for the patients in the high stage group was higher receiving immunotherapy than those not treated. This suggests that immunotherapy may be useful for prolonging the survival time of patients with advanced bladder carcinoma. |
URI: | http://hdl.handle.net/2433/120107 |
PubMed ID: | 6677093 |
出現コレクション: | Vol.29 No.1 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。